Keratoconus is a progressive eye disorder that affects the cornea, the clear, dome-shaped front surface of the eye. In this condition, the cornea gradually thins and bulges into a cone-like shape, leading to visual distortions and potential vision impairment.
An eye care professional can diagnose keratoconus through a comprehensive eye exam, which may include corneal mapping (topography) and measurements of corneal thickness.
Corneal cross-linking (CXL) is a treatment designed to prevent progression of corneal weakness. This treatment is recommended for patients whose corneal scans show evidence of worsening keratoconus, or those judged to be at especially high risk of the conditioning worsening. As cross-linking of the collagen within the cornea naturally increases with age, the progression of keratoconus usually stops when patients enter their mid-30s, so it is not usually required for older patients.
Corneal Cross-Linking will not reverse keratoconus but in the majority of cases prevents the condition from worsening, and in some cases, will achieve significant improvement in vision.
Corneal Cross-Linking is a minimally invasive procedure. It slows or halts the progression of keratoconus by increasing the strength of the natural fibres within the cornea. It does not cure the condition.
The cornea consists of a number of layers of which the stroma is responsible for strength. The stroma consists of millions of collagen fibres in close contact with each other which gives shape and structure to that area. These fibres are responsible for preventing the cornea from bulging out and becoming steep and irregular, which is what happens when a patient develops keratoconus.
The Cross-Linking treatment used at Optimax employs a combination of Riboflavin (Vitamin B) drops and ultra violet light that reacts with the collagen fibres in the cornea, strengthening them by creating more 'cross-linking' among them, and mimicking the natural corneal stiffening which occurs with age. The resulting increased strength of the cornea inhibits the progression of keratoconus. The procedure is usually pain-free.
The cost for this treatment is £2,495 per eye. Different treatment payment methods and easy payment plans are available at Optimax. Consultations with us cost £50.